Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;96:1119-1126
Published online before print May 5, 2005, doi: 10.1161/01.RES.0000168740.04986.a7
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
96/10/1119    most recent
01.RES.0000168740.04986.a7v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sonveaux, P.
Right arrow Articles by Dewhirst, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sonveaux, P.
Right arrow Articles by Dewhirst, M. W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
*OXYGEN
Related Collections
Right arrow Other hypertension
Right arrow Hypertension - basic studies
Right arrow Ischemic biology - basic studies
Right arrow Other Treatment
Right arrow Endothelium/vascular type/nitric oxide
(Circulation Research. 2005;96:1119.)
© 2005 American Heart Association, Inc.


Integrative Physiology

Oxygen Regulation of Tumor Perfusion by S-Nitrosohemoglobin Reveals a Pressor Activity of Nitric Oxide

Pierre Sonveaux, Andrew M. Kaz, Stacey A. Snyder, Rachel A. Richardson, L. Isabel Cárdenas-Navia, Rodney D. Braun, John R. Pawloski, Gillian M. Tozer, Joseph Bonaventura, Timothy J. McMahon, Jonathan S. Stamler, Mark W. Dewhirst

From the Department of Radiation Oncology (P.S., A.M.K., S.A.S., R.A.R., L.I.C.-N., R.D.B., M.W.D.), Howard Hughes Medical Institute (J.S.S.) and Department of Medicine (J.R.P., T.J.M., J.S.S.), Duke University Medical Center, Durham, NC; Nicholas School of the Environment and Earth Sciences, Duke University Marine Laboratory, and University of Puerto Rico NIH COBREII Protein Research Center, Beaufort, NC and Mayaguez PR00681 (J.B.); and Tumor Microcirculation Group, Gray Cancer Institute, Mount Vernon Hospital, Northwood, Middlesex, UK (G.M.T).

Correspondence to Mark W. Dewhirst, Department of Radiation Oncology, Box 3455, Room 201 MSRB, Duke University Medical Center, Research Drive, Durham, NC 27710. Email dewhirst{at}radonc.duke.edu

In erythrocytes, S-nitrosohemoglobin (SNO-Hb) arises from S-nitrosylation of oxygenated hemoglobin (Hb). It has been shown that SNO-Hb behaves as a nitric oxide (NO) donor at low oxygen tensions. This property, in combination with oxygen transport capacity, suggests that SNO-Hb may have unique potential to reoxygenate hypoxic tissues. The present study was designed to test the idea that the allosteric properties of SNO-Hb could be manipulated to enhance oxygen delivery in a hypoxic tumor. Using Laser Doppler flowmetry, we showed that SNO-Hb infusion to animals breathing 21% O2 reduced tumor perfusion without affecting blood pressure and heart rate. Raising the pO2 (100% O2) slowed the release of NO bioactivity from SNO-Hb (ie, prolonged the plasma half-life of the SNO in Hb), preserved tumor perfusion, and raised the blood pressure. In contrast, native Hb reduced both tumor perfusion and heart rate independently of the oxygen concentration of the inhaled gas, and did not elicit hypertensive effects. Window chamber (to image tumor arteriolar reactivity in vivo) and hemodynamic measurements indicated that the preservation of tissue perfusion by micromolar concentrations of SNO-Hb is a composite effect created by reduced peripheral vascular resistance and direct inhibition of the baroreceptor reflex, leading to increased blood pressure. Overall, these results indicate that the properties of SNO-Hb are attributable to allosteric control of NO release by oxygen in central as well as peripheral issues.


Key Words: nitric oxide • hemoglobin • oxygen • hemodynamics • blood flow




This article has been cited by other articles:


Home page
Circ. Res.Home page
D. L. Diesen, D. T. Hess, and J. S. Stamler
Hypoxic Vasodilation by Red Blood Cells: Evidence for an S-Nitrosothiol-Based Signal
Circ. Res., August 29, 2008; 103(5): 545 - 553.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. D. Reynolds, G. S. Ahearn, M. Angelo, J. Zhang, F. Cobb, and J. S. Stamler
S-nitrosohemoglobin deficiency: A mechanism for loss of physiological activity in banked blood
PNAS, October 23, 2007; 104(43): 17058 - 17062.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
P. Sonveaux, I. I. Lobysheva, O. Feron, and T. J. McMahon
Transport and Peripheral Bioactivities of Nitrogen Oxides Carried by Red Blood Cell Hemoglobin: Role in Oxygen Delivery
Physiology, April 1, 2007; 22(2): 97 - 112.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
B. Gaston, D. Singel, A. Doctor, and J. S. Stamler
S-Nitrosothiol Signaling in Respiratory Biology
Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1186 - 1193.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
B. Gaston
Summary: systemic effects of inhaled nitric oxide.
Proceedings of the ATS, January 1, 2006; 3(2): 170 - 172.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. J. McMahon, G. S. Ahearn, M. P. Moya, A. J. Gow, Y.-C. T. Huang, B. P. Luchsinger, R. Nudelman, Y. Yan, A. D. Krichman, T. M. Bashore, et al.
A nitric oxide processing defect of red blood cells created by hypoxia: Deficiency of S-nitrosohemoglobin in pulmonary hypertension
PNAS, October 11, 2005; 102(41): 14801 - 14806.
[Abstract] [Full Text] [PDF]